scholarly journals Diverse Presentations of Carcinoma Erysipelatoides from a Teaching Hospital in Australia

2012 ◽  
Vol 2012 ◽  
pp. 1-5 ◽  
Author(s):  
Hui Ting Chow ◽  
Kim Tran ◽  
Ewan K. A. Millar ◽  
Jodi Lynch ◽  
Dedee F. Murrell
Keyword(s):  
Breast Cancer ◽  
Case Series ◽  
Multimodality Treatment ◽  
Metastatic Carcinoma ◽  
Delay In Diagnosis ◽  
Imaging Results ◽  
History Of ◽  
Previously Treated ◽  
Cancer Specialists ◽  
Treated Breast

Inflammatory breast carcinoma is a rare form of advanced breast cancer which carries a poor prognosis, even with treatment. Diagnosis is reached on clinical and pathological grounds; however, due to its propensity to mimic other conditions, it may often be delayed or missed by attending physicians. This case series describes four patients seen at our institution with a diagnosis of inflammatory breast cancer; 3 patients had a history of previously treated breast malignancy. In these cases, the emergence of a new breast lesion evaded initial diagnosis due to incomplete initial physical examination, falsely reassuring imaging results, lack of recognition that a cellulitis picture can resemble metastatic carcinoma, and inconclusive initial biopsy sections. These obstacles to achieve diagnosis serve to further worsen the prognosis by delaying the initiation of multimodality treatment which can improve survival. The purpose of our paper is to increase awareness among breast cancer specialists of the importance of undressing the patient for basic clinical examination of the breasts, recognition of the appearances of this type of local recurrence of breast cancer, and not to rely purely on ultrasound and mammography due to delay in diagnosis in some of our local cases. Sometimes deeper sections and repeat biopsies are needed to make the diagnosis.

scholarly journals Excision of metastatic breast cancer from sternum and reconstruction in two patients with solitary metastatic spread

2020 ◽  
Vol 2020 (8) ◽  
Author(s):  
Saifullah Mohamed ◽  
Khurum Mazhar ◽  
Ahmed Osman ◽  
Akshay Patel ◽  
Lakshmi Srinivasan ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Carcinoma ◽  
Previous History ◽  
Metastatic Breast ◽  
Extent Of Resection ◽  
Left Breast ◽  
Term Survival ◽  
Metastatic Breast Carcinoma ◽  
History Of ◽  
Treated Breast

Abstract Metastatic breast carcinoma is a relatively common clinical entity. However, the prognosis of oligometastatic and polygometastatic disease differs considerably pertaining to five-year survival. Metastatic breast carcinoma to the sternum has been described as early as 1988. We describe two cases in our institution who presented with solitary sternal metastases with a previous history of treated breast cancer. In both cases, there had been a history of previous left breast cancer treated aggressively with surgical resection and adjuvant oncological therapy and maintenance hormonal therapy. Partial sternectomy or total sternectomy for solitary metastatic sternal deposits is well established with relatively low morbidity and mortality and improvement in quality of life and possible improvement in long-term survival. Furthermore, reconstructive options are inherently dependent on extent of resection performed. These techniques can incorporate the use of sternal plates in order to approximate defects and reinforce the sternum in the setting of partial sternectomy.

Pattern of breast diseases in Kuwait Cancer Control Center, Kuwait

2006 ◽  
Vol 24 (18_suppl) ◽  
pp. 10754-10754 ◽  
Author(s):  
S. A. Alawadi ◽  
M. D. Delvadiya
Keyword(s):  
Breast Cancer ◽  
Hormone Replacement ◽  
Case Series ◽  
Breast Diseases ◽  
Age At Menarche ◽  
Female Breast ◽  
N2 Disease ◽  
Case Series Study ◽  
History Of ◽  
Second Degree

10754 Background: The aim of this case series study is to evaluate the outline and pattern of female breast cancers in Kuwait. Methods: Our study consisted of data from 300 cases of female breast cancer seen in our outpatient department. Data on profile of their disease at presentation and known risk factors was retrieved. The analysis indented to examine the pattern of the disease and risk factor profile of the patients. Results: Out of 300 patients, 52% were Kuwaiti citizens, 24% were Arabs from other countries, 23% were of Asian origin and 1% was of other nationality. Their median age ± SD (Standard Deviation) was 50 ± 9.7 years. Most patients were younger than 55 years (77.4%) and were predominantly premenopausals (63%). Only 18% had stage I disease at presentation, whilst 54 %, 24 %, and 4% had stage II, III and IV disease, respectively. Among patients with known axillary nodal status (298 patients) 44.3% were node-negative whilst 39.6% and 16.8% had N1 and N2 disease, respectively. History of benign breast disease was positive in 9% and only 1% had breast biopsy done before the biopsy which diagnosed cancer. In 20.7% there was family history of breast cancer. Among them 11.7% had first degree relative with breast cancer, 3.3%, 7.3% and 1% patients had either mother, sister or both with history of breast cancer. Whilst 12% patients had second degree relatives with breast cancer, 3% patients out of them had both first and second degree relatives with breast cancer. History of alcohol ingestion was rare, only 0.7% patients were taking alcohol. 9.7% patients were nulliparous, while 10.7% patients had their first child after the age of 30 years. Breast feeding was common, 80 % patients breast fed their children and 43.3 % did that for more than 6 months. Age at menarche was 12 years or less in 34 % patients and age at menopause was more than 55 years in only 6.3% patients. Oral contraceptives were used by 38.7% patients, 12%, 9.3% and 17.3% patients used them for 2 or less, 2 to 5 or more than 5 years, respectively. Only 3% patients took hormone replacement therapy, 7 of them took that fore more than 2 years. Only 6 % patients gave history of smoking and only half of them were currently smoking. Conclusions: This data analysis suggested that pattern of breast cancer in Kuwait is similar to other countries in this region. No significant financial relationships to disclose.

Childbirth in young Korean women with previously treated breast cancer: The SMARTSHIP study

2019 ◽  
Vol 176 (2) ◽  
pp. 419-427 ◽  
Author(s):  
Hak Min Lee ◽  
Bo Wook Kim ◽  
Seho Park ◽  
Sungmin Park ◽  
Jeon Eon Lee ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Korean Women ◽  
Previously Treated ◽  
Treated Breast ◽  
Treated Breast Cancer

Mitomycin C and Vinblastine: An Active Regimen in Previously Treated Breast Cancer Patients

2009 ◽  
Vol 95 (6) ◽  
pp. 683-686 ◽  
Author(s):  
Inna Ospovat ◽  
Nava Siegelmann-Danieli ◽  
Tal Grenader ◽  
Ayala Hubert ◽  
Tamar Hamburger ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Mitomycin C ◽  
Breast Cancer Patients ◽  
Previously Treated ◽  
Treated Breast ◽  
Treated Breast Cancer

Acupuncture in the Rehabilitation of Women after Breast Cancer Surgery – a Case Series

2008 ◽  
Vol 26 (2) ◽  
pp. 86-93 ◽  
Author(s):  
Michele Alem ◽  
Maria Salete Costa Gurgel
Keyword(s):  
Breast Cancer ◽  
Case Series ◽  
Cancer Surgery ◽  
Breast Cancer Surgery ◽  
Movement Amplitude ◽  
Range Of Movement ◽  
Shoulder Flexion ◽  
Friedman's Test ◽  
Before And After ◽  
History Of

Objective To evaluate the effect of acupuncture on rehabilitation of motor function, reduction in lymphoedema and improvement in perceived heaviness and tightness in the arms of women who had undergone breast cancer surgery. Subjects and Methods Twenty nine women who had had mastectomy or segmentectomy with axillary dissection, presenting with lymphoedema and/or a decrease in movement amplitude of the upper limb ipsilateral to surgery were studied. The patients underwent 24 acupuncture sessions once a week from February to December 2004. The movement amplitude of shoulder flexion and abduction and circumferential measurements of the arm, forearm and wrist were evaluated before and after one, three and six months of treatment. Statistical analysis was performed by Friedman's test. Results Significant improvements in range of movement of shoulder flexion and abduction (P<0.001), degree of lymphoedema (P=0.016), and sense of heaviness and tightening (P<0.001) in the affected limb after six months of therapy were observed. For circumferential measurements of the arm, forearm and wrist, no significant improvement between the different periods of treatment was observed. Conclusions Acupuncture in rehabilitation after breast cancer surgery was shown to be associated with improvements in movement amplitude of the shoulder, symptoms of heaviness and tightness in the arm, and the degree of lymphoedema. However, controlled trials should be performed to ascertain whether the results were due to the natural history of the complaint or the acupuncture treatment.

scholarly journals Diagnostic performance of abbreviated breast MRI for screening of women with previously treated breast cancer

Medicine ◽  
2020 ◽  
Vol 99 (16) ◽  
pp. e19676 ◽  
Author(s):  
Mi-ri Kwon ◽  
Eun Young Ko ◽  
Boo-Kyung Han ◽  
Eun Sook Ko ◽  
Ji Soo Choi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Diagnostic Performance ◽  
Breast Mri ◽  
Previously Treated ◽  
Abbreviated Breast Mri ◽  
Treated Breast ◽  
Treated Breast Cancer

scholarly journals Breast Carcinoma After Ocrelizumab Therapy in Multiple Sclerosis Patients: A Case Series and Literature Review

2021 ◽  
Vol 13 ◽  
pp. 117957352110377
Author(s):  
Andrew Kelsey ◽  
Gabriella Casinelli ◽  
Medha Tandon ◽  
Shitiz Sriwastava
Keyword(s):  
Breast Cancer ◽  
Multiple Sclerosis ◽  
Breast Carcinoma ◽  
Literature Review ◽  
Case Reports ◽  
Case Series ◽  
Progressive Multiple Sclerosis ◽  
Primary Progressive Multiple Sclerosis ◽  
History Of ◽  
Multiple Sclerosis Patients

Ocrelizumab is a humanized CD20 monoclonal antibody which was approved for management of Relapsing Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS) in 2017. We present 2 patients, a 67-year-old woman with history of PPMS and a 42-year-old woman with RRMS, who were started on ocrelizumab and were diagnosed with invasive ductal cell breast carcinoma after 2 years of ocrelizumab infusion followed by discontinuation of the drug. Large trials conducted for ocrelizumab showed malignancies in a total of 4 cases with RRMS in OPERA 1 trial conducted over 2 years from 2011 to 2013 (breast cancer, renal cell carcinoma, and melanomas) and in 11 cases with PPMS seen in ORATORIO trial conducted in 2017. There are currently no other published case reports of breast cancer in setting of ocrelizumab use for MS outside of large trials on literature review.

Sign in / Sign up

Export Citation Format

Share Document